Current Opinion in Neurology

Article	Citations
SEEG in 2025: progress and pending challenges in stereotaxy methods, biomarkers and radiofrequency thermocoagulation	63
Autoimmune movement disorders with neuronal antibodies – an update	57
Learning from the comorbidities of epilepsy	55
Update on genetics of amyotrophic lateral sclerosis	52
Headache in infections	51
How can you manage an indomethacin-responsive headache in someone who cannot take indomethacin?	47
Ultra-high dose methylcobalamin and other emerging therapies for amyotrophic lateral sclerosis	41
Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and management	38
Rescue therapies in epilepsy	37
Advanced neuroimaging techniques in epilepsy	36
Editorial introductions	36
Editorial introductions	32
Editorial: Clinical epileptology entering the era of personalized medicine	31
Insights into a personalized management of blood pressure in acute stroke	27
Cancer stem cells in gliomas: evolving concepts and therapeutic implications	25
Primary central nervous system vasculitis and headache: Ten themes	24
The recent surge of functional movement disorders: social distress or greater awareness?	23
Update on neuroimaging in brain tumours	23
MRI and laboratory monitoring of disease-modifying therapy efficacy and risks	23
Abnormal energy metabolism in ALS: a key player?	22
Sudden unexpected death in epilepsy	22
Guillain-Barré syndrome in an era of global infections and 21st century vaccination	21
Management of neuropsychiatric symptoms in dementia	20
Old muscle, new tricks: a clinician perspective on sarcopenia and where to next	20
Recent advances in our understanding of genetic rhabdomyolysis	20

New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome	19
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis	19
Promises and pitfalls of imaging-based biomarkers in motor neuron diseases	19
Fluid phase biomarkers in multiple sclerosis	19
Update on neuroimaging in Alzheimer's disease	18
Deciphering the contributions of neuroinflammation to neurodegeneration: lessons from antibody-mediated encephalitis and coronavirus disease 2019	18
Traumatic brachial plexus injury: diagnosis and treatment	18
Endogenous clues promoting remyelination in multiple sclerosis	18
Neuropathogenesis of acute coronavirus disease 2019	17
Editorial: Neuromuscular diseases: differential diagnosis and targeted treatment	17
Editorial: Current opinions in neurology editorial	17
PET-based brain molecular connectivity in neurodegenerative disease	17
Neuropathology and epilepsy surgery	17
Neuromuscular complications of cancer therapy	17
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management	17
The state of art on the use of patient reported outcomes in migraine	16
Hypoventilation syndrome in neuromuscular disorders	16
Editorial: Degenerative and cognitive diseases	16
Editorial introductions	16
Visually induced dizziness	16
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation	15
An update on the role of focused ultrasound in neuro-oncology	15
Neuropathology and neuroanatomy of TDP-43 amyotrophic lateral sclerosis	15
Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health	15
Diagnosing viral encephalitis and emerging concepts	14
Reproducibility and replicability in neuroimaging data analysis	14
Chemotherapy and targeted therapies for meningiomas: what is the evidence?	14
Update on management of cerebral venous thrombosis	13
Socioeconomic disparities in epilepsy care	13
The genetics of amyotrophic lateral sclerosis	13
Addressing vaccine-preventable encephalitis in vulnerable populations: Erratum	13
Cerebral amyloid angiopathy: one single entity?	13
Recent insights in striated muscle laminopathies	13
The optic nerve in spaceflight: novel concepts in the pathogenesis of optic disc edema in microgravity	13
Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications	13
Current trend in air pollution exposure and stroke	13
Understanding multiple sclerosis as a disease spectrum: above and below the clinical threshold	13
An update on Becker muscular dystrophy	13
Intravenous thrombolysis for acute ischemic stroke: why not?	13
Pregnancy and reproductive health in women with multiple sclerosis: an update	12
Monitoring multiple sclerosis: digital and fluid phase biomarkers	12
Central vestibular networking for sensorimotor control, cognition, and emotion	12
Congenital myasthenic syndromes: increasingly complex	12
Pharmacological treatment for older adults with epilepsy and comorbid neurodegenerative disorders	12
Cannabinoids in headache: helpful or harmful?	12
Hereditary motor neuropathies	11
Diagnostic criteria for amyotrophic lateral sclerosis	11
Therapeutic developments for valosin-containing protein mediated multisystem proteinopathy	11
Central nervous system adverse events of immune checkpoint inhibitors	11
A patient with neuropathy and ataxia: what do I have to consider?	11

Contraception, fecundity, and pregnancy in women with epilepsy: an update on recent literature	11
Noninvasive neuromodulation and rehabilitation to promote functional restoration in persons with spinal cord injury	11
What visuospatial perception has taught us about the pathophysiology of vestibular migraine	10
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies	10
T cell dysfunction in glioblastoma: a barrier and an opportunity for the development of successful immunotherapies	10
Imaging cortical lesions in multiple sclerosis	10
Editorial: Making the invisible visible: updates on vestibular neurology	10
Noninvasive brain stimulation to improve motor outcomes after stroke	10
Triggers of migraine: where do we stand?	10
Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum	10
Editorial introductions	9
Recent insights into haematology and peripheral nerve disease	9
Neurology education in the era of artificial intelligence	9
The atypical faces of optic neuritis: neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease	9
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease	9
Precision medicine in secondary prevention of ischemic stroke: how may blood-based biomarkers help in clinical routine? An expert opinion	9
Gene therapies for CMT neuropathies: from the bench to the clinic	9
Visual snow syndrome: recent advances in understanding the pathophysiology and potential treatment approaches	9
Fragile X-associated tremor/ataxia syndrome: pathophysiology and management	8
Prevention of epileptogenesis – are we there yet?	8
Editorial introductions	8
Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection	8
Sleep and circadian rhythm dysfunctions in movement disorders beyond Parkinson's disease and atypical parkinsonisms	8
The role of caffeine in headache disorders	8
New knowledge on anti-IgLON5 disease	8
Historical development and contemporary use of neuromodulation in human spinal cord injury	8
Noninvasive methods to monitor intracranial pressure	8
Editorial introductions	8
Microglia in multiple sclerosis – pathogenesis and imaging	8
From basic mechanisms to therapeutic perspectives in cluster headache	8
Autoimmune neuromyotonia	8
The 2021 WHO classification of central nervous system tumors: what neurologists need to know	8
Neuroscience and oncology: state-of-the-art and new perspectives	8
Advances in functional and structural imaging of the brainstem: implications for disease	8
Myoclonus: an update	8
The role of the gut microbiome in Alzheimer's disease pathophysiology	7
Vestibular contribution to spatial orientation and navigation	7
Bilateral vestibulopathy: the causes, diagnosis, and treatments	7
Long COVID and especially headache syndromes	7
Vestibular migraine: an update	7
Parkinson's disease – current treatment	7
Update on modifiable risk factors for Alzheimer's disease and related dementias	7
Leprous neuropathy	7
Seizure prediction and forecasting: a scoping review	7
Neurological adverse events of immune checkpoint blockade: from pathophysiology to treatment	7
Epidemiology and genetics of Meniere's disease	7
Artificial intelligence and machine learning in disorders of consciousness	7
Traumatic peripheral nerve injuries: diagnosis and management	7
Editorial introductions	6
Update on myelin imaging in neurological syndromes	6
Web-based cognitive assessment in older adults: Where do we stand?	6
New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise	6
Equitable partnerships between scientists and persons living with spinal cord injury will strengthen research scope, quality, and outcomes	6
Editorial: Update on current topics in traumatic spinal cord injury	6
Editorial introductions	6
Development of neural repair therapy for chronic spinal cord trauma: soluble nogo receptor decoy from discovery to clinical trial	6
Editorial: Understanding factors that, beyond plaques and tangles, contribute to the heterogeneity of Alzheimer disease and implications for the development of biomarkers and design of interventions	6
Editorial introductions	6
Neuronal antibodies in nonparaneoplastic autoimmune cerebellar ataxias	6
New and emerging pharmacologic treatments for developmental and epileptic encephalopathies	6
Updates in neuro-otology	6
Editorial: Central nervous system inflammatory injury, and now in the time of epidemic	6
Immune checkpoint inhibitors induced side effects of the peripheral nervous system	6
Network dysfunction in pre and postsurgical epilepsy: connectomics as a tool and not a destination	6
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection	6
Vitamins in neuropathy: pathophysiological and therapeutic roles	5
Novel pathophysiological insights in autoimmune myasthenia gravis	5
New developments in myotonic dystrophies from a multisystemic perspective	5
Pharmacotherapy of cerebellar and vestibular disorders	5
Myogenic tremor – a novel tremor entity	5
An update on multiple system atrophy	5
Peripheral visual field loss and activities of daily living	5
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients	5
Novel approaches to measuring neurocognitive functions in Alzheimer's disease clinical trials	5
Autoimmune nodopathies, an emerging diagnostic category	5
Is thrombectomy indicated in all ischemic stroke with large vessel occlusion?	5
Editorial introductions	5
Degenerative and cognitive diseases	5
Editorial: Epilepsy advances in 2023	5
Editorial introductions	5

Critical care EEG monitoring: improving access and unravelling potentially epileptic patterns	5
Persistent challenges in endovascular treatment decision-making for acute ischaemic stroke	5
Urogenital dysfunction following neurotrauma	5
Data-driven approaches to neuroimaging biomarkers for neurological and psychiatric disorders: emerging approaches and examples	5
New insights into the Immune TME of adult-type diffuse gliomas	5
Therapies targeting CGRP signaling for medication overuse headache	5
Editorial: Seizure disorders: 2023 update	5
Editorial: Advances in Multiple Sclerosis	5
In-vivo diagnosis of cerebral amyloid angiopathy: an updated review	4
Does imaging of the ischemic penumbra have value in acute ischemic stroke with large vessel occlusion?	4
Emerging approaches in neurostimulation for epilepsy	4
Blood and cerebrospinal fluid biomarkers in neuro-oncology	4
Mechanisms of coronavirus infectious disease 2019-related neurologic diseases	4
Current gaps in acute reperfusion therapies	4
Progress in the mechanism of neuronal surface P antigen modulating hippocampal function and implications for autoimmune brain disease	4
Sudden unexpected death in epilepsy	4
Motion sickness: current concepts and management	4
Editorial introductions	4
Mechanisms of autoimmune encephalitis	4
Cycling multisensory changes in migraine: more than a headache	4
Muscle ultrasound in myopathies	4
Clinical characteristics of patients with myelin oligodendrocyte glycoprotein antibodies	4
Editorial: Update on movement disorders	4
Therapeutic strategies for C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia	4
Medical and neurologic management of brain tumor patients	4
Multiple sclerosis in china: the current state of diagnosis and management	4
Editorial introductions	4
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery	3
Progress in treatment of gliomas	3
Clinical impact of molecular profiling in rare brain tumors	3
Therapeutic thoroughfares for adults living with Pompe disease	3
Recent advances in epilepsy surgery	3
The evolving spectrum of complex inherited neuropathies	3
Update on neuroimaging in non-Alzheimer's disease dementia: a focus on the Lewy body disease spectrum	3
Current avenues of gene therapy in Pompe disease	3
Targeting Bruton's tyrosine kinase in primary central nervous system lymphoma	3
Is calcitonin gene-related peptide a reliable biochemical marker of migraine?	3
Pan-Neurofascin autoimmune nodopathy – a life-threatening, but reversible neuropathy	3
Update on RYR1-related myopathies	3
Revascularization of arterial occlusions in posterior circulation acute ischemic stroke	3
Antibody testing in neuropathy associated with anti-Myelin-Associated Glycoprotein antibodies: where we are after 40 years	3
Connecting tremors – a circuits perspective	3
Advances in neuroimaging of multiple sclerosis	3
CAR T-cell therapy for gliomas	3
Threat of resurgence or hope for global eradication of poliovirus?	3
Pure autonomic failure and the differential diagnosis of autonomic peripheral neuropathies	3
Perception and control of a virtual body in immersive virtual reality for rehabilitation	3
Freezing of gait: pharmacological and surgical options	3
Editorial introductions	3
Prehospital stroke management and mobile stroke units	3
Chronic and delayed neurological manifestations of persistent infections	3
Pathological insights derived from neuroimaging in amyotrophic lateral sclerosis: emerging clinical applications	3
Treatment discontinuation in older people with multiple sclerosis	3
The challenge of amyotrophic lateral sclerosis descriptive epidemiology: to estimate low incidence rates across complex phenotypes in different geographic areas	3